Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.431ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.431ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.168EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.168ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.168ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.168EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.168EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.168ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.168ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.6 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.6 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.6 (Alpha)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Q.6 (Alpha)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Q.6 (Alpha)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Q.6 (Alpha)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Q.6 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.6 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.77EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.77ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.77ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.77EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
BA.2.77EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
BA.2.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CP.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CP.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CP.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CP.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
FC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BY.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BY.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BY.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BY.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BY.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used